Spire Wealth Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16
Closed -$2K 2666
2022
Q1
$2K Hold
16
﹤0.01% 2375
2021
Q4
$3K Sell
16
-9
-36% -$2.12K ﹤0.01% 2678
2021
Q3
$6K Hold
25
﹤0.01% 2224
2021
Q2
$10K Sell
25
-2
-7% -$792 ﹤0.01% 2102
2021
Q1
$10K Buy
+27
New +$13.3K ﹤0.01% 2403

Other funds holding BLUE

Spire Wealth Management's BLUE Position: Q2 2022 in Review

Spire Wealth Management sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 16 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in BLUE in Q1 2021 and held it in 5 quarters. The position peaked at $10K in Q2 2021. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Spire Wealth Management reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Spire Wealth Management sold 16 bluebird bio shares in Q2 2022, an estimated $2K.
  • Spire Wealth Management first reported a position in bluebird bio in Q1 2021 and held it in 5 quarters.
  • Spire Wealth Management's bluebird bio position peaked at $10K in Q2 2021.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.